Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ikena Oncology, Inc.

1.43
0.0000
Volume:- -
Turnover:- -
Market Cap:69.01M
PE:- -
High:1.43
Open:1.43
Low:1.43
Close:1.43
52wk High:23.28
52wk Low:1.43
Shares:48.26M
Float Shares:33.28M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.0202
ROE:-23.76%
ROA:-18.32%
PB:0.60
PE(LYR):-1.40

Loading ...

Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 29, 2025

Major Issues Report

Form 8-K - Current report
Jul 25, 2025

Major Issues Report

Form 8-K - Current report
Jul 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2025

Major Issues Report

Form 8-K - Current report
Jul 22, 2025

Major Issues Report

Form 8-K - Current report
Jul 16, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Major Issues Report

Form 8-K - Current report
Jul 11, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 11, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 06, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 23, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]